STOCK TITAN

[SCHEDULE 13D/A] Artivion, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

Juniper Investment-affiliated reporting persons amended their Schedule 13D to report a decrease in their beneficial ownership of Artivion, Inc. common stock to 1,864,449 shares, representing approximately 4.0% of outstanding shares as of the record date. Between June 17, 2025 and August 11, 2025 Juniper Targeted Opportunities, L.P. sold 233,715 shares in the open market for an aggregate sale price of approximately $9,540,725, which includes brokerage commissions. Percentages are calculated using 47,183,656 shares outstanding as of August 1, 2025.

The filing breaks out ownership by entity: Juniper Fund holds 1,473,656 shares (about 3.1%), Juniper Targeted Opportunities holds 377,308 shares (about 0.8%), and Juniper Multi-Strategy holds 13,485 shares (about 0.0%). Juniper Investment Company and the named managing members may be deemed to beneficially own the aggregate shares but disclaim ownership for other purposes. The amendment references a Joint Filing Agreement and a schedule of transactions as exhibits.

Le persone informanti collegate a Juniper Investment hanno aggiornato il loro Schedule 13D per comunicare una riduzione della partecipazione beneficiaria nelle azioni ordinarie di Artivion, Inc., portandola a 1.864.449 azioni, pari a circa il 4,0% delle azioni in circolazione alla data di riferimento. Tra il 17 giugno 2025 e l'11 agosto 2025 Juniper Targeted Opportunities, L.P. ha venduto 233.715 azioni sul mercato aperto per un incasso complessivo di circa $9.540.725, comprensivo delle commissioni di intermediazione. Le percentuali sono calcolate sulla base di 47.183.656 azioni in circolazione al 1º agosto 2025.

La documentazione suddivide la detenzione per entità: Juniper Fund detiene 1.473.656 azioni (circa il 3,1%), Juniper Targeted Opportunities detiene 377.308 azioni (circa lo 0,8%) e Juniper Multi-Strategy detiene 13.485 azioni (circa lo 0,0%). Juniper Investment Company e i membri gestori indicati possono essere ritenuti titolari benefici dell'ammontare aggregato, pur disconoscendo la proprietà ai fini di altri scopi. L'emendamento fa riferimento a un Joint Filing Agreement e a un prospetto delle transazioni come allegati.

Las personas informantes vinculadas a Juniper Investment enmendaron su Schedule 13D para notificar una disminución en su propiedad beneficiaria de las acciones ordinarias de Artivion, Inc., dejándola en 1.864.449 acciones, lo que representa aproximadamente el 4,0% del capital en circulación en la fecha de registro. Entre el 17 de junio de 2025 y el 11 de agosto de 2025, Juniper Targeted Opportunities, L.P. vendió 233.715 acciones en el mercado abierto por un importe agregado de aproximadamente $9.540.725, incluidas las comisiones de corretaje. Los porcentajes se calculan usando 47.183.656 acciones en circulación al 1 de agosto de 2025.

La presentación desglosa la tenencia por entidad: Juniper Fund posee 1.473.656 acciones (aprox. 3,1%), Juniper Targeted Opportunities posee 377.308 acciones (aprox. 0,8%) y Juniper Multi-Strategy posee 13.485 acciones (aprox. 0,0%). Juniper Investment Company y los miembros administradores nombrados pueden considerarse beneficiarios de la titularidad agregada de las acciones, aunque renuncian a la propiedad para otros fines. La enmienda hace referencia a un Joint Filing Agreement y a un calendario de operaciones como anexos.

Juniper Investment 관련 보고인들이 Schedule 13D를 수정하여 Artivion, Inc. 보통주에 대한 실질적 소유 지분이 1,864,449주로 감소했음을 보고했습니다. 이는 기준일 기준 약 4.0%에 해당합니다. 2025년 6월 17일과 2025년 8월 11일 사이 Juniper Targeted Opportunities, L.P.는 공개 시장에서 233,715주를 매도했으며, 총 매도 대금은 중개 수수료를 포함해 약 $9,540,725였습니다. 비율은 2025년 8월 1일 기준 유통 주식수 47,183,656주를 기준으로 계산되었습니다.

신고서는 보유를 법인별로 구분하여 기재합니다: Juniper Fund는 1,473,656주(약 3.1%), Juniper Targeted Opportunities는 377,308주(약 0.8%), Juniper Multi-Strategy는 13,485주(약 0.0%)를 보유하고 있습니다. Juniper Investment Company 및 명시된 운영 멤버들은 총 보유 주식의 실질적 소유자로 간주될 수 있으나, 다른 목적상 소유권을 부인합니다. 수정 서류에는 공동 제출 계약(Joint Filing Agreement)과 거래 내역 일정이 첨부 문서로 언급되어 있습니다.

Les personnes déclarantes affiliées à Juniper Investment ont modifié leur Schedule 13D pour signaler une diminution de leur détention bénéficiaire des actions ordinaires d'Artivion, Inc., portée à 1 864 449 actions, soit environ 4,0 % des actions en circulation à la date d'enregistrement. Entre le 17 juin 2025 et le 11 août 2025, Juniper Targeted Opportunities, L.P. a vendu 233 715 actions sur le marché ouvert pour un produit brut d'environ 9 540 725 $, y compris les commissions de courtage. Les pourcentages sont calculés sur la base de 47 183 656 actions en circulation au 1er août 2025.

Le dépôt détaille la détention par entité : Juniper Fund détient 1 473 656 actions (environ 3,1 %), Juniper Targeted Opportunities détient 377 308 actions (environ 0,8 %) et Juniper Multi-Strategy détient 13 485 actions (environ 0,0 %). Juniper Investment Company et les membres gérants nommés peuvent être réputés détenir bénéficiairement le total des actions, tout en déclinant la propriété à d'autres fins. L'amendement fait référence à un Joint Filing Agreement et à un calendrier des transactions en tant que pièces jointes.

Berichtspflichtige im Zusammenhang mit Juniper Investment haben ihren Schedule 13D geändert, um eine Verringerung ihres wirtschaftlichen Eigentums an den Stammaktien von Artivion, Inc. auf 1.864.449 Aktien zu melden, was etwa 4,0% der ausstehenden Aktien zum Stichtag entspricht. Zwischen dem 17. Juni 2025 und dem 11. August 2025 verkaufte Juniper Targeted Opportunities, L.P. 233.715 Aktien am offenen Markt zu einem Gesamtverkaufserlös von rund $9.540.725, einschließlich Maklergebühren. Die Prozentsätze basieren auf 47.183.656 ausstehenden Aktien zum 1. August 2025.

Die Einreichung gliedert das Eigentum nach Einheiten: Juniper Fund hält 1.473.656 Aktien (ca. 3,1%), Juniper Targeted Opportunities hält 377.308 Aktien (ca. 0,8%) und Juniper Multi-Strategy hält 13.485 Aktien (ca. 0,0%). Juniper Investment Company und die genannten geschäftsführenden Mitglieder können als wirtschaftliche Eigentümer der aggregierten Aktien angesehen werden, lehnen jedoch eine Eigentumszuschreibung für andere Zwecke ab. Die Änderung verweist auf eine gemeinsame Einreichungsvereinbarung (Joint Filing Agreement) und einen Transaktionszeitplan als Anlagen.

Positive
  • Transparent disclosure: The Reporting Persons filed an amendment to disclose the sale and updated beneficial ownership figures.
  • Current ownership reported: Aggregate beneficial ownership of 1,864,449 shares, representing approximately 4.0% of outstanding shares as of the record date.
  • Transaction details provided: The amendment specifies the number of shares sold (233,715) and the aggregate sale proceeds (approximately $9,540,725 including commissions).
Negative
  • Reduction in stake: Reporting Persons sold shares, resulting in a decreased beneficial ownership percentage.
  • Concentrated disposals: 233,715 shares were sold in the open market between June 17, 2025 and August 11, 2025 for approximately $9,540,725, reducing the group’s position.

Insights

TL;DR: Juniper disclosed an open-market sale reducing its Artivion stake to 4.0% after selling 233,715 shares for about $9.54M.

The amendment reports a non-controlling but material passive position of 1,864,449 shares, calculated on 47,183,656 shares outstanding as of August 1, 2025. The sale generated approximately $9.54 million including commissions and occurred in the open market between June 17, 2025 and August 11, 2025. The filing clarifies which affiliated entities hold voting and dispositive power and identifies the named managing members who signed the amendment.

TL;DR: The Schedule 13D/A updates ownership, voting and dispositive allocations among related Juniper entities and attaches required exhibits for transparency.

The filing details entity-level holdings and explicitly states which entities have sole voting and dispositive power over their respective shares while noting that Juniper Investment Company and the managing members may be deemed to beneficially own the aggregate shares but disclaim ownership for other purposes. Exhibits include a Joint Filing Agreement and a schedule of transactions, ensuring coordinated disclosure by the group.

Le persone informanti collegate a Juniper Investment hanno aggiornato il loro Schedule 13D per comunicare una riduzione della partecipazione beneficiaria nelle azioni ordinarie di Artivion, Inc., portandola a 1.864.449 azioni, pari a circa il 4,0% delle azioni in circolazione alla data di riferimento. Tra il 17 giugno 2025 e l'11 agosto 2025 Juniper Targeted Opportunities, L.P. ha venduto 233.715 azioni sul mercato aperto per un incasso complessivo di circa $9.540.725, comprensivo delle commissioni di intermediazione. Le percentuali sono calcolate sulla base di 47.183.656 azioni in circolazione al 1º agosto 2025.

La documentazione suddivide la detenzione per entità: Juniper Fund detiene 1.473.656 azioni (circa il 3,1%), Juniper Targeted Opportunities detiene 377.308 azioni (circa lo 0,8%) e Juniper Multi-Strategy detiene 13.485 azioni (circa lo 0,0%). Juniper Investment Company e i membri gestori indicati possono essere ritenuti titolari benefici dell'ammontare aggregato, pur disconoscendo la proprietà ai fini di altri scopi. L'emendamento fa riferimento a un Joint Filing Agreement e a un prospetto delle transazioni come allegati.

Las personas informantes vinculadas a Juniper Investment enmendaron su Schedule 13D para notificar una disminución en su propiedad beneficiaria de las acciones ordinarias de Artivion, Inc., dejándola en 1.864.449 acciones, lo que representa aproximadamente el 4,0% del capital en circulación en la fecha de registro. Entre el 17 de junio de 2025 y el 11 de agosto de 2025, Juniper Targeted Opportunities, L.P. vendió 233.715 acciones en el mercado abierto por un importe agregado de aproximadamente $9.540.725, incluidas las comisiones de corretaje. Los porcentajes se calculan usando 47.183.656 acciones en circulación al 1 de agosto de 2025.

La presentación desglosa la tenencia por entidad: Juniper Fund posee 1.473.656 acciones (aprox. 3,1%), Juniper Targeted Opportunities posee 377.308 acciones (aprox. 0,8%) y Juniper Multi-Strategy posee 13.485 acciones (aprox. 0,0%). Juniper Investment Company y los miembros administradores nombrados pueden considerarse beneficiarios de la titularidad agregada de las acciones, aunque renuncian a la propiedad para otros fines. La enmienda hace referencia a un Joint Filing Agreement y a un calendario de operaciones como anexos.

Juniper Investment 관련 보고인들이 Schedule 13D를 수정하여 Artivion, Inc. 보통주에 대한 실질적 소유 지분이 1,864,449주로 감소했음을 보고했습니다. 이는 기준일 기준 약 4.0%에 해당합니다. 2025년 6월 17일과 2025년 8월 11일 사이 Juniper Targeted Opportunities, L.P.는 공개 시장에서 233,715주를 매도했으며, 총 매도 대금은 중개 수수료를 포함해 약 $9,540,725였습니다. 비율은 2025년 8월 1일 기준 유통 주식수 47,183,656주를 기준으로 계산되었습니다.

신고서는 보유를 법인별로 구분하여 기재합니다: Juniper Fund는 1,473,656주(약 3.1%), Juniper Targeted Opportunities는 377,308주(약 0.8%), Juniper Multi-Strategy는 13,485주(약 0.0%)를 보유하고 있습니다. Juniper Investment Company 및 명시된 운영 멤버들은 총 보유 주식의 실질적 소유자로 간주될 수 있으나, 다른 목적상 소유권을 부인합니다. 수정 서류에는 공동 제출 계약(Joint Filing Agreement)과 거래 내역 일정이 첨부 문서로 언급되어 있습니다.

Les personnes déclarantes affiliées à Juniper Investment ont modifié leur Schedule 13D pour signaler une diminution de leur détention bénéficiaire des actions ordinaires d'Artivion, Inc., portée à 1 864 449 actions, soit environ 4,0 % des actions en circulation à la date d'enregistrement. Entre le 17 juin 2025 et le 11 août 2025, Juniper Targeted Opportunities, L.P. a vendu 233 715 actions sur le marché ouvert pour un produit brut d'environ 9 540 725 $, y compris les commissions de courtage. Les pourcentages sont calculés sur la base de 47 183 656 actions en circulation au 1er août 2025.

Le dépôt détaille la détention par entité : Juniper Fund détient 1 473 656 actions (environ 3,1 %), Juniper Targeted Opportunities détient 377 308 actions (environ 0,8 %) et Juniper Multi-Strategy détient 13 485 actions (environ 0,0 %). Juniper Investment Company et les membres gérants nommés peuvent être réputés détenir bénéficiairement le total des actions, tout en déclinant la propriété à d'autres fins. L'amendement fait référence à un Joint Filing Agreement et à un calendrier des transactions en tant que pièces jointes.

Berichtspflichtige im Zusammenhang mit Juniper Investment haben ihren Schedule 13D geändert, um eine Verringerung ihres wirtschaftlichen Eigentums an den Stammaktien von Artivion, Inc. auf 1.864.449 Aktien zu melden, was etwa 4,0% der ausstehenden Aktien zum Stichtag entspricht. Zwischen dem 17. Juni 2025 und dem 11. August 2025 verkaufte Juniper Targeted Opportunities, L.P. 233.715 Aktien am offenen Markt zu einem Gesamtverkaufserlös von rund $9.540.725, einschließlich Maklergebühren. Die Prozentsätze basieren auf 47.183.656 ausstehenden Aktien zum 1. August 2025.

Die Einreichung gliedert das Eigentum nach Einheiten: Juniper Fund hält 1.473.656 Aktien (ca. 3,1%), Juniper Targeted Opportunities hält 377.308 Aktien (ca. 0,8%) und Juniper Multi-Strategy hält 13.485 Aktien (ca. 0,0%). Juniper Investment Company und die genannten geschäftsführenden Mitglieder können als wirtschaftliche Eigentümer der aggregierten Aktien angesehen werden, lehnen jedoch eine Eigentumszuschreibung für andere Zwecke ab. Die Änderung verweist auf eine gemeinsame Einreichungsvereinbarung (Joint Filing Agreement) und einen Transaktionszeitplan als Anlagen.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Juniper Targeted Opportunity Fund, L.P.
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member of its General Partner, Juniper HF Investors II, LLC
Date:08/11/2025
Juniper HF Investors II, LLC
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member
Date:08/11/2025
Juniper Targeted Opportunities, L.P.
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member of its General Partner, Juniper Targeted Opportunity Investors, LLC
Date:08/11/2025
Juniper Targeted Opportunity Investors, LLC
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member
Date:08/11/2025
Juniper Multi-Strategy Fund, L.P.
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member of its General Partner, Juniper HF Investors
Date:08/11/2025
Juniper HF Investors, LLC
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member
Date:08/11/2025
Juniper Investment Company, LLC
Signature:/s/ John A. Bartholdson
Name/Title:Managing Member
Date:08/11/2025
Alexis P. Michas
Signature:/s/ Alexis P. Michas
Name/Title:Alexis P. Michas
Date:08/11/2025
John A. Bartholdson
Signature:/s/ John A. Bartholdson
Name/Title:John P. Bartholdson
Date:08/11/2025

FAQ

What stake does Juniper report in Artivion (AORT)?

The Reporting Persons collectively beneficially own 1,864,449 shares, representing approximately 4.0% of Artivion's outstanding common stock based on 47,183,656 shares as of the August 1, 2025 record date.

How many shares did Juniper sell and for how much?

Juniper Targeted Opportunities, L.P. sold 233,715 shares in the open market for an aggregate sale price of approximately $9,540,725, including brokerage commissions, between June 17, 2025 and August 11, 2025.

Which Juniper entities hold Artivion shares and what are their amounts?

Juniper Targeted Opportunity Fund, L.P. holds 1,473,656 shares (about 3.1%), Juniper Targeted Opportunities, L.P. holds 377,308 shares (about 0.8%), and Juniper Multi-Strategy Fund, L.P. holds 13,485 shares (about 0.0%).

Who are the reporting persons and signatories on the filing?

The filing is by multiple Juniper entities and individuals, including Juniper Investment Company, LLC and managing members Alexis P. Michas and John A. Bartholdson. Contact details for notices include Juniper Investment Company, LLC at 555 Madison Avenue, 24th Floor, New York, NY 10022 and phone (212) 339-8500.

What exhibits were filed with the Schedule 13D/A?

Exhibit B: Joint Filing Agreement (incorporated by reference) and Exhibit C: Schedule of Transactions.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

2.07B
42.07M
5.01%
98.51%
2.89%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW